Form 4: Powell Anderson Capital Partners Increases Stake in Psychemedics Corp

Powell Anderson Capital Partners and related entities have increased their holdings in Psychemedics Corp through a series of open market purchases.

Summary

• Powell Anderson Capital Partners LLC, along with related entities PACP Jupiter LLC and Powell Anderson Capital LP, have acquired additional shares of Psychemedics Corp (PMD).
• These transactions occurred between December 13, 2024, and December 17, 2024.
• The purchases were made at prices ranging from $1.87 to $1.97 per share.
• A total of 159,700 shares were acquired across the various entities.
• Following these transactions, the entities collectively own 984,256 shares of Psychemedics Corp.
• The shares are held indirectly through PACP Jupiter LLC and Powell Anderson Capital LP.
• R. Adam Lindsay, as Managing Member of Powell Anderson Capital Partners LLC, has the power to vote and dispose of these shares.

Sentiment

Score: 6

Explanation: The document indicates increased investment by a significant shareholder, which is generally positive, but the lack of context makes it difficult to assess the overall impact.

Positives

• The increased stake by Powell Anderson Capital Partners could indicate confidence in Psychemedics Corp's future prospects.
• The purchases were made at prices ranging from $1.87 to $1.97 per share, suggesting a belief in the company's value at these levels.

Risks

• The document does not provide any information about the reasons for the purchases, so it is difficult to assess the long-term implications.
• The document only reflects the transactions of one entity and does not provide a complete picture of all trading activity in Psychemedics Corp.

Industry Context

This filing is a standard SEC Form 4, which is used to report changes in beneficial ownership by company insiders. It is common for investment firms to adjust their holdings in publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are a standard part of the US stock market and are required by the SEC.
• The level of detail provided in this filing is consistent with other Form 4 filings.
• The transactions are relatively small compared to the overall market capitalization of Psychemedics Corp, but are significant for the reporting entity.

Stakeholder Impact

• The increased stake by Powell Anderson Capital Partners could be viewed positively by other shareholders.
• The transactions may have a minor impact on the share price of Psychemedics Corp.

Key Dates

Keywords

Psychemedics Corp, Powell Anderson Capital Partners, share purchase, insider trading, equity, PMD, stake, investment